Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Tirasemtiv

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cytokinetics' Astellas-partnered ALS drug misses goal in phase 2
    Cytokinetics' Astellas-partnered ALS drug misses goal in phase 2

    07 May 2019

    // Nick P. Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cytokinetics-astellas-partnered-als-drug-misses-goal-phase-2

    Nick P. Taylor FIERCE BIOTECH
    07 May 2019
    Share Share
    Orion takes repurposed heart drug into phase 3 for ALS
    Orion takes repurposed heart drug into phase 3 for ALS

    06 Jul 2018

    // Phil Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/orion-take-repurposed-heart-failure-drug-into-phase-3-for-als

    Phil Taylor FIERCE BIOTECH
    06 Jul 2018
    Share Share
    Solid Bio back in business after the FDA lifts hold on DMD gene therapy
    Solid Bio back in business after the FDA lifts hold on DMD gene therapy

    18 Jun 2018

    // John Carroll ENDPTS

    https://endpts.com/solid-bio-is-back-in-business-after-the-fda-lifts-clinical-hold-on-duchenne-md-gene-therapy/

    John Carroll ENDPTS
    18 Jun 2018
    Share Share